Boardroom Alpha
Start trial
8-K/A primary document
RRX · Amended Current Report (Form 8-K/A) · Filed March 16, 2026

Regal Rexnord Corp — 8-K/A exhibit

ex10-1.htm
Regal Rexnord Corp on Boardroom Alpha
Exhibit 10.1


March 15, 2026


Louis V. Pinkham
Chief Executive Officer
Regal Rexnord Corporation
c/o last address on file


Dear Louis:

Reference is made to the Transition Agreement and General Release of Claims, dated as of October 27, 2025 (the “Transition Agreement”), between you and Regal Rexnord Corporation (the “Company”).  All capitalized terms used but not defined herein shall have the meanings ascribed to them in the Transition Agreement.  This letter serves as an addendum to modify the terms of the Transition Agreement, as described in Section IV.K. thereof.

The Transition Agreement is hereby amended to provide that the Termination Date (and your employment) is extended from March 31, 2026 until June 30, 2026 (or such earlier date as mutually agreed between you and the Company in another addendum), and that the Transition Date shall be no later than June 30, 2026.  In connection with your continued service, for each of the three months ending on the extended Termination Date, you will receive (1) continued payment of your base salary for the period you remain employed and (2) a cash payment equal to $770,833.33 (representing one-twelfth of your annual target bonus and long-term incentive target amount) for each month of the extended transition period (maximum payments of $2,312,500), pro-rated for partial months of employment in the event of a Termination Date prior to June 30, 2026, and payable no later than the second payroll date following the end of the applicable calendar month.  Payments described in this paragraph shall not reduce or offset the payments due to you under Section I.B. of the Transition Agreement, which shall continue to be due and payable as of the Termination Date in accordance with, and subject to the terms of, the Transition Agreement and Regal Rexnord Corporation Executive Severance Policy.

Except as amended in the above paragraph, the terms of the Transition Agreement shall remain in full force and effect.  This letter may be executed in counterparts, and signatures delivered electronically shall be deemed to be an executed original thereof.



We thank you for your continued service to Regal Rexnord.


  REGAL REXNORD CORPORATION,  
       

By:
/s/ Hugo Dubovoy, Jr.  
    Name:   Hugo Dubovoy, Jr.
 
    Title:
EVP, General Counsel and
Corporate Secretary
  
       
 
Accepted and agreed:        
         
         
/s/ Louis V. Pinkham
   

 
Louis V. Pinkham
    

 

   

 


Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer